Home › Trial NCT01718743
Ixazomib Citrate and Lenalidomide After Stem Cell Transplant in Treating Patients With Newly Diagnosed Multiple Myeloma
- Trial IDNCT01718743
- StatusCompleted
- PhasePhase 2
- Study typeInterventional
- SponsorM.D. Anderson Cancer Center
- Enrollment64
- Start date2012-12-03
- ConditionsHematopoietic Cell Transplantation Recipient · Plasma Cell Myeloma
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.